Meningitis vaccine how supplied

Meningitis vaccine

MENVEO® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Chetan Lokhande, M.B.B.S [2]

## How Supplied

[edit | edit source]

MENVEO product presentation is listed in Table 11 below. The container closures (synthetic rubber stoppers) do not contain latex.

[[File:|800px|thumb]]

### Storage and Handling

[edit | edit source]

Do not freeze. Frozen/previously frozen product should not be used.

Store refrigerated, away from the freezer compartment, at 36°F to 46°F (2°C to 8°C).

Protect from light. Vaccine must be maintained at 36°F to 46°F during transport.

Do not use after the expiration date. The reconstituted vaccine should be used immediately, but may be held at or below 77°F (25°C) for up to 8 hours.[1]

## References

[edit | edit source]

1. ↑ "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89dde472-1efb-4630-88bc-41cde216fb3a". External link in `|title=` (help)

Adapted from the FDA Package Insert.